ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs”

October 30, 1998